(Q41017454)

25 September 2017

title

Effect of postoperative wound infection on the course of stage II melanoma (English)

1 reference

10.1002/1097-0142(197903)43:3<1106::AID-CNCR2820430349>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1106::AID-CNCR2820430349%3E3.0.CO;2-M

10 April 2023

1 reference

10.1002/1097-0142(197903)43:3<1106::AID-CNCR2820430349>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1106::AID-CNCR2820430349%3E3.0.CO;2-M

10 April 2023

author name string

D. N. Papachristou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A371784

10 April 2023

J. G. Fortner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A371784

10 April 2023

language of work or name

English

0 references

publication date

1 March 1979

1 reference

full work available at URL

25 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197903)43:3%3C1106::AID-CNCR2820430349%3E3.0.CO;2-M

1 reference

10.1002/1097-0142(197903)43:3<1106::AID-CNCR2820430349>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1106::AID-CNCR2820430349%3E3.0.CO;2-M

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197903)43:3%3C1106::AID-CNCR2820430349%3E3.0.CO;2-M

10 April 2023

1 reference

10.1002/1097-0142(197903)43:3<1106::AID-CNCR2820430349>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1106::AID-CNCR2820430349%3E3.0.CO;2-M

10 April 2023

1 reference

25 September 2017

volume

43

1 reference

25 September 2017

issue

3

1 reference

25 September 2017

page(s)

1106-1111

1 reference

Immunological Effects of BCG in Malignant Melanoma: Two Modes of Administration Compared

25 September 2017

cites work

3

1 reference

10.1002/1097-0142(197903)43:3<1106::AID-CNCR2820430349>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1106::AID-CNCR2820430349%3E3.0.CO;2-M

MELANOTIC CANCER: WITH A REPORT OF 91 CASES

10 April 2023

8

1 reference

10.1002/1097-0142(197903)43:3<1106::AID-CNCR2820430349>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1106::AID-CNCR2820430349%3E3.0.CO;2-M

Treatment of primary melanoma by intralesional vaccinia before excision

10 April 2023

9

1 reference

10.1002/1097-0142(197903)43:3<1106::AID-CNCR2820430349>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1106::AID-CNCR2820430349%3E3.0.CO;2-M

Active immunotherapy with B.C.G. for recurrent malignant melanoma

10 April 2023

13

1 reference

10.1002/1097-0142(197903)43:3<1106::AID-CNCR2820430349>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1106::AID-CNCR2820430349%3E3.0.CO;2-M

Control of Carcinogenesis: A Possible Role for the Activated Macrophage

10 April 2023

17

1 reference

10.1002/1097-0142(197903)43:3<1106::AID-CNCR2820430349>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1106::AID-CNCR2820430349%3E3.0.CO;2-M

Selective cytotoxicity of peritoneal leucocytes for neoplastic cells

10 April 2023

18

1 reference

10.1002/1097-0142(197903)43:3<1106::AID-CNCR2820430349>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1106::AID-CNCR2820430349%3E3.0.CO;2-M

In vitro destruction of tumor cells by human monocytes

10 April 2023

19

1 reference

10.1002/1097-0142(197903)43:3<1106::AID-CNCR2820430349>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1106::AID-CNCR2820430349%3E3.0.CO;2-M

Use of Vaccinia Virus in the Treatment of Metastatic Malignant Melanoma

10 April 2023

20

1 reference

10.1002/1097-0142(197903)43:3<1106::AID-CNCR2820430349>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1106::AID-CNCR2820430349%3E3.0.CO;2-M

10 April 2023

24

29

2351

Klein

1969

1 reference

10.1002/1097-0142(197903)43:3<1106::AID-CNCR2820430349>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1106::AID-CNCR2820430349%3E3.0.CO;2-M

DELAYED HYPERSENSITIVITY RESPONSE TO DNFB IN SICK AND HEALTHY PERSONS

10 April 2023

28

1 reference

10.1002/1097-0142(197903)43:3<1106::AID-CNCR2820430349>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1106::AID-CNCR2820430349%3E3.0.CO;2-M

The immunologic and histopathologic changes of BCG-mediated tumor regression in patients with malignant melanoma

10 April 2023

29

1 reference

10.1002/1097-0142(197903)43:3<1106::AID-CNCR2820430349>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1106::AID-CNCR2820430349%3E3.0.CO;2-M

Spontaneous regression of malignant melanoma. Pathologic and immunologic study in a ten year survivor

10 April 2023

30

1 reference

10.1002/1097-0142(197903)43:3<1106::AID-CNCR2820430349>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1106::AID-CNCR2820430349%3E3.0.CO;2-M

Iatrogenic Immunotherapy of Lung Cancer

10 April 2023

33

1 reference

10.1002/1097-0142(197903)43:3<1106::AID-CNCR2820430349>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1106::AID-CNCR2820430349%3E3.0.CO;2-M

Immunological Aspects of Neoplasia: A Rational Basis for Immunotherapy

10 April 2023

36

1 reference

10.1002/1097-0142(197903)43:3<1106::AID-CNCR2820430349>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1106::AID-CNCR2820430349%3E3.0.CO;2-M

BCG immunotherapy of malignant melanoma: summary of a seven-year experience

10 April 2023

37

1 reference

10.1002/1097-0142(197903)43:3<1106::AID-CNCR2820430349>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1106::AID-CNCR2820430349%3E3.0.CO;2-M

10 April 2023

42

21

1281

Old

1961

1 reference

10.1002/1097-0142(197903)43:3<1106::AID-CNCR2820430349>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1106::AID-CNCR2820430349%3E3.0.CO;2-M

Effect of Bacillus Calmette-Guérin Infection on Transplanted Tumours in the Mouse

10 April 2023

43

1 reference

10.1002/1097-0142(197903)43:3<1106::AID-CNCR2820430349>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1106::AID-CNCR2820430349%3E3.0.CO;2-M

Note on the experimental use of rabies vaccine for melanomatosis

10 April 2023

45

1 reference

10.1002/1097-0142(197903)43:3<1106::AID-CNCR2820430349>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1106::AID-CNCR2820430349%3E3.0.CO;2-M

Postoperative empyema improves survival in lung cancer. Documentation and analysis of a natural experiment

10 April 2023

48

1 reference

10.1002/1097-0142(197903)43:3<1106::AID-CNCR2820430349>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1106::AID-CNCR2820430349%3E3.0.CO;2-M

Cytotoxic Effect of Lymphocyte-Antigen Interaction in Delayed Hypersensitivity

10 April 2023

49

1 reference

10.1002/1097-0142(197903)43:3<1106::AID-CNCR2820430349>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1106::AID-CNCR2820430349%3E3.0.CO;2-M

Cell Migration Inhibition Factor released by Antigen from Human Peripheral Lymphocytes

10 April 2023

54

1 reference

10.1002/1097-0142(197903)43:3<1106::AID-CNCR2820430349>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1106::AID-CNCR2820430349%3E3.0.CO;2-M

Unblocking or activation of the cellular immune mechanism by induced proteolysis in patients with cancer.

10 April 2023

55

1 reference

10.1002/1097-0142(197903)43:3<1106::AID-CNCR2820430349>3.0.CO;2-M

https://api.crossref.org/works/10.1002/1097-0142(197903)43:3%3C1106::AID-CNCR2820430349%3E3.0.CO;2-M

10 April 2023

Identifiers

10.1002/1097-0142(197903)43:3<1106::AID-CNCR2820430349>3.0.CO;2-M

1 reference

25 September 2017

1 reference